Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$145.54 - $178.83 $3.09 Million - $3.79 Million
-21,214 Reduced 91.09%
2,074 $359,000
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $3.86 Million - $4.66 Million
23,288 New
23,288 $3.94 Million
Q3 2023

Nov 14, 2023

SELL
$167.14 - $192.77 $270,766 - $312,287
-1,620 Reduced 33.15%
3,267 $568,000
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $167,216 - $193,492
1,039 Added 27.0%
4,887 $841,000
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $559,807 - $673,476
3,848 New
3,848 $640,000
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $2.61 Million - $3.35 Million
-16,749 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$181.39 - $234.03 $2.06 Million - $2.66 Million
11,362 Added 210.92%
16,749 $3.16 Million
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $600,439 - $765,793
-3,100 Reduced 36.53%
5,387 $1.32 Million
Q3 2021

Nov 15, 2021

SELL
$189.29 - $209.69 $219,197 - $242,821
-1,158 Reduced 12.01%
8,487 $1.65 Million
Q2 2021

Aug 16, 2021

BUY
$155.9 - $187.99 $742,239 - $895,020
4,761 Added 97.48%
9,645 $1.8 Million
Q1 2021

May 17, 2021

SELL
$144.0 - $169.39 $474,048 - $557,631
-3,292 Reduced 40.26%
4,884 $769,000
Q4 2020

Feb 16, 2021

BUY
$157.07 - $174.35 $313,982 - $348,525
1,999 Added 32.36%
8,176 $1.35 Million
Q3 2020

Nov 16, 2020

SELL
$137.1 - $165.37 $190,157 - $229,368
-1,387 Reduced 18.34%
6,177 $1.02 Million
Q2 2020

Aug 14, 2020

BUY
$111.92 - $142.53 $846,562 - $1.08 Million
7,564 New
7,564 $1.04 Million
Q1 2020

May 15, 2020

SELL
$92.66 - $144.94 $483,963 - $757,021
-5,223 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$116.25 - $133.25 $607,173 - $695,964
5,223 New
5,223 $691,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.